Sandeep Bhuta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sandeep Bhuta has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Charlie Chia-Tsong Hsu
Division of Neuroradiology, Department of Medical Imaging, Gold Coast University Hospital, Australia
3 shared publications Charlie C.-T. Hsu
Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia
2 shared publicationsGigi N.C. Kwan
Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia
2 shared publicationsGigi Nga Chi Kwan
Department of Medical Imaging, Gold Coast University Hospital, Southport, Queensland, Australia
2 shared publicationsQueenie Lau
2 shared publications- Simon A. Broadley
School of Medicine and Dentistry, Griffith University, Gold Coast, Qld, Australia
2 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 5, e101944
AI Adoption, Adaptation, and Workforce Sustainability in Medical Imaging: Systematic Review and Conceptual Framework
Background: Despite growing recognition that AI-driven systems offer transformative benefits for diagnostic imaging, insufficient evidence exists regarding how medical imaging workforces adapt to AI technology to support workforce sustainability. Objective: The aim of this study is to systematically review the existing literature on perceptions and attitudes toward AI adoption in medical imaging, postadoption adaptation behaviors within the workforce, and the implications of these processes for workforce sustainability. Methods: Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, a systematic search was carried out across 7 databases. Thematic analysis was used to systematically identify, analyze, and interpret patterns across the literature, providing a comprehensive understanding of workforce perceptions and adaptation behaviors. Results: A total of 69 peer-reviewed articles were included for thematic synthesis. The findings produced 6 critical factors that were identified as themes associated with AI adoption: perceived benefits, trust, readiness to change, autonomy and control, perceived threat to professional identity, and attitudes and intentions toward AI adoption and use. Four key facets of effective cognitive and behavioral adaptation were identified: training and skills development, task performance during AI-assisted practice, reduction of mental health burden and work strain, and policy compliance. The influence of work engagement and job satisfaction on workforce sustainability was also conceptualized. The findings were integrated into a framework describing the radiology workforce perspectives on AI adoption, adaptation behaviors, and workforce sustainability. Conclusions: The findings have potential implications for policy, particularly in strengthening AI-equipped medical imaging systems, fostering trust in AI-driven technologies, and supporting workforce training and upskilling, while considering professional autonomy and role identity. The review highlights a research gap, emphasizing the need for further investigation into postadoption adaptation processes and informing policy development that links AI integration with long-term workforce sustainability in medical imaging.
- 3 November 2026
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 5, e101944
Open AccessAI Adoption, Adaptation, and Workforce Sustainability in Medical Imaging: Systematic Review and Conceptual Framework
Background: Despite growing recognition that AI-driven systems offer transformative benefits for diagnostic imaging, insufficient evidence exists regarding how medical imaging workforces adapt to AI technology to support workforce sustainability. Objective: The aim of this study is to systematically review the existing literature on perceptions and attitudes toward AI adoption in medical imaging, postadoption adaptation behaviors within the workforce, and the implications of these processes for workforce sustainability. Methods: Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, a systematic search was carried out across 7 databases. Thematic analysis was used to systematically identify, analyze, and interpret patterns across the literature, providing a comprehensive understanding of workforce perceptions and adaptation behaviors. Results: A total of 69 peer-reviewed articles were included for thematic synthesis. The findings produced 6 critical factors that were identified as themes associated with AI adoption: perceived benefits, trust, readiness to change, autonomy and control, perceived threat to professional identity, and attitudes and intentions toward AI adoption and use. Four key facets of effective cognitive and behavioral adaptation were identified: training and skills development, task performance during AI-assisted practice, reduction of mental health burden and work strain, and policy compliance. The influence of work engagement and job satisfaction on workforce sustainability was also conceptualized. The findings were integrated into a framework describing the radiology workforce perspectives on AI adoption, adaptation behaviors, and workforce sustainability. Conclusions: The findings have potential implications for policy, particularly in strengthening AI-equipped medical imaging systems, fostering trust in AI-driven technologies, and supporting workforce training and upskilling, while considering professional autonomy and role identity. The review highlights a research gap, emphasizing the need for further investigation into postadoption adaptation processes and informing policy development that links AI integration with long-term workforce sustainability in medical imaging.
- Open Access
- 7 August 2025
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (9) , 1-12
Characteristics of MRI lesions in AQP4 antibody-positive NMOSD, MOGAD, and multiple sclerosis: a systematic review and meta-analysis
Background and objectives: Multiple sclerosis (MS), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-Ab + ve NMOSD), and myelin oligodendrocyte glycoprotein-associated disease (MOGAD) are demyelinating diseases with differing pathophysiological processes and treatments. The objective of this study was to compile a comprehensive list of MRI lesions, and to quantify the utility of these lesions in distinguishing between these conditions. Methods: We searched for articles comparing MRI lesion frequency in MS, AQP4-Ab + ve NMOSD, MOGAD and healthy controls. Bayesian network meta-analysis together with pairwise and pooled case-case comparison analyses to develop sensitivity, specificity, and positive predictive values were undertaken. Results: Sixty-six articles were reported on 2933 MS, 3296 AQP4-Ab + ve NMOSD, and 1559 MOGAD cases, and 561 healthy controls. MRI lesions associated with MS were: periventricular T2, subcortical white matter T2, Dawson's finger, U-fibre T2 lesion, posterior spinal column T2, inferior temporal T2, cortical T2, brain T1 hypointensity (black holes), peripheral spinal cord T2, pons T2, unilateral optic nerve T2 and brain gadolinium enhancing lesions. Optic chiasm T2, LETM, bright spotty spinal cord T2, area postrema T2, hypothalamic T2, spinal cord atrophy and optic tract T2 lesions were associated with AQP4-Ab + ve NMOSD. Conus medullaris T2, fluffy, perineural enhancement, peri-ependymal 3rd ventricle T2 and peri-ependymal 4th ventricle T2 lesions were associated with MOGAD. Discussion: This review identified MRI features supportive of a diagnosis of MS, NMOSD or MOGAD, and has clarified the diagnostic utility of various MRI lesion characteristics, to aid in future clinical decision-making and guide future approaches to research.
- 7 August 2025
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (9) , 1-12
Open AccessCharacteristics of MRI lesions in AQP4 antibody-positive NMOSD, MOGAD, and multiple sclerosis: a systematic review and meta-analysis
Background and objectives: Multiple sclerosis (MS), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-Ab + ve NMOSD), and myelin oligodendrocyte glycoprotein-associated disease (MOGAD) are demyelinating diseases with differing pathophysiological processes and treatments. The objective of this study was to compile a comprehensive list of MRI lesions, and to quantify the utility of these lesions in distinguishing between these conditions. Methods: We searched for articles comparing MRI lesion frequency in MS, AQP4-Ab + ve NMOSD, MOGAD and healthy controls. Bayesian network meta-analysis together with pairwise and pooled case-case comparison analyses to develop sensitivity, specificity, and positive predictive values were undertaken. Results: Sixty-six articles were reported on 2933 MS, 3296 AQP4-Ab + ve NMOSD, and 1559 MOGAD cases, and 561 healthy controls. MRI lesions associated with MS were: periventricular T2, subcortical white matter T2, Dawson's finger, U-fibre T2 lesion, posterior spinal column T2, inferior temporal T2, cortical T2, brain T1 hypointensity (black holes), peripheral spinal cord T2, pons T2, unilateral optic nerve T2 and brain gadolinium enhancing lesions. Optic chiasm T2, LETM, bright spotty spinal cord T2, area postrema T2, hypothalamic T2, spinal cord atrophy and optic tract T2 lesions were associated with AQP4-Ab + ve NMOSD. Conus medullaris T2, fluffy, perineural enhancement, peri-ependymal 3rd ventricle T2 and peri-ependymal 4th ventricle T2 lesions were associated with MOGAD. Discussion: This review identified MRI features supportive of a diagnosis of MS, NMOSD or MOGAD, and has clarified the diagnostic utility of various MRI lesion characteristics, to aid in future clinical decision-making and guide future approaches to research.
- Open Access
- 11 June 2024
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (8) , 5275-5289
Long-term outcomes of ADEM-like and tumefactive presentations of CNS demyelination: a case-comparison analysis
A minority of initial multiple sclerosis (MS) presentations clinically or radiologically resemble other central nervous system (CNS) pathologies, acute disseminated encephalomyelitis (ADEM) or tumefactive demyelination (atypical demyelination presentations). With the aim of better defining the long-term outcomes of this group we have performed a retrospective cohort comparison of atypical demyelination versus ‘typical’ MS presentations. Twenty-seven cases with atypical presentations (both first and subsequent demyelinating events) were identified and compared with typical MS cases. Disease features analysed included relapse rates, disability severity, whole brain and lesion volumes, lesion number and distribution. Atypical cases represented 3.9% of all MS cases. There was considerable overlap in the magnetic resonance imaging (MRI) features of ADEM-like and tumefactive demyelination cases. ADEM-like cases tended to be younger but not significantly so. Atypical cases showed a trend towards higher peak expanded disability severity score (EDSS) score at the time of their atypical presentation. Motor, cranial nerve, cerebellar, cerebral and multifocal presentations were all more common in atypical cases, and less likely to present with optic neuritis. Cerebrospinal fluid (CSF) white cell counts were higher in atypical cases (p = 0.002). One atypical case was associated with peripheral blood myelin oligodendrocyte glycoprotein (MOG) antibodies, but subsequent clinical and radiological course was in keeping with MS. There was no difference in long-term clinical outcomes including annualised relapse rates (ARR), brain volume, lesion numbers or lesion distributions. Atypical demyelination cases were more likely to receive high potency disease modifying therapy early in the course of their illness. Despite the severity of initial illness, our cohort analysis suggests that atypical demyelination presentations do not confer a higher risk of long-term adverse outcomes.
- 11 June 2024
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (8) , 5275-5289
Open AccessLong-term outcomes of ADEM-like and tumefactive presentations of CNS demyelination: a case-comparison analysis
A minority of initial multiple sclerosis (MS) presentations clinically or radiologically resemble other central nervous system (CNS) pathologies, acute disseminated encephalomyelitis (ADEM) or tumefactive demyelination (atypical demyelination presentations). With the aim of better defining the long-term outcomes of this group we have performed a retrospective cohort comparison of atypical demyelination versus ‘typical’ MS presentations. Twenty-seven cases with atypical presentations (both first and subsequent demyelinating events) were identified and compared with typical MS cases. Disease features analysed included relapse rates, disability severity, whole brain and lesion volumes, lesion number and distribution. Atypical cases represented 3.9% of all MS cases. There was considerable overlap in the magnetic resonance imaging (MRI) features of ADEM-like and tumefactive demyelination cases. ADEM-like cases tended to be younger but not significantly so. Atypical cases showed a trend towards higher peak expanded disability severity score (EDSS) score at the time of their atypical presentation. Motor, cranial nerve, cerebellar, cerebral and multifocal presentations were all more common in atypical cases, and less likely to present with optic neuritis. Cerebrospinal fluid (CSF) white cell counts were higher in atypical cases (p = 0.002). One atypical case was associated with peripheral blood myelin oligodendrocyte glycoprotein (MOG) antibodies, but subsequent clinical and radiological course was in keeping with MS. There was no difference in long-term clinical outcomes including annualised relapse rates (ARR), brain volume, lesion numbers or lesion distributions. Atypical demyelination cases were more likely to receive high potency disease modifying therapy early in the course of their illness. Despite the severity of initial illness, our cohort analysis suggests that atypical demyelination presentations do not confer a higher risk of long-term adverse outcomes.
- 16 February 2021
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 65 (2) , 175-181
Oropharyngeal squamous cell carcinomas: Can imaging findings predict HPV status?
Purpose: This is first Australian population‐based retrospective study in HPV‐induced OPSCCs utilising CT. Contrast enhanced computed tomography (CECT) was utilised to assess if imaging findings of metastatic cystic lymph nodes (LNs) can predict human papillomavirus (HPV) status, as defined by p16 immunostaining of oropharyngeal squamous cell carcinomas (OPSCCs).Materials and Methods: The location and p16 status of primary tumours and LNs were recorded. Metastatic LNs were assessed for size, shape, margins and cystic changes. Hounsfield Units (HU) value of primary tumours and LNs were measured and tabulated. p16‐positive and p16‐negative groups were compared with respect to these variables. The two‐sample t test and two‐sample Mann–Whitney test was used.Results: A total of 364 CECT scans were reviewed with 209 patients (187 p16 positive and 22 p16 negative). Primary sites of OPSCCs were tonsils (58.8%), base of tongue (37.4%) and other oropharyngeal sites (3.8%). The HU values of p16‐positive OPSCCs with mean of 78.6HU; 95% CI (76.5–80.8) were lower for p16‐negative tumours, mean 96.0 HU CI 95% (85.5–106.6) for all oropharyngeal sub‐sites. The mean HU values of p16‐positive and p16‐negative metastatic LNs were 38.8 HU 95% CI: (13–103 HU) versus 88.7 HU 95% CI: (54–131) (P < 0.0001).Conclusions: The association between p16‐positive status and the tonsillar cancer site is very high. Imaging features of p16‐positive metastatic LNs include relatively large cystic neck nodes with low HU values. This is an imaging signature of p16‐positive OPSCCs and can potentially influence patient’s early diagnosis and prognosis.
- 16 February 2021
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 65 (2) , 175-181
Oropharyngeal squamous cell carcinomas: Can imaging findings predict HPV status?
Purpose: This is first Australian population‐based retrospective study in HPV‐induced OPSCCs utilising CT. Contrast enhanced computed tomography (CECT) was utilised to assess if imaging findings of metastatic cystic lymph nodes (LNs) can predict human papillomavirus (HPV) status, as defined by p16 immunostaining of oropharyngeal squamous cell carcinomas (OPSCCs).Materials and Methods: The location and p16 status of primary tumours and LNs were recorded. Metastatic LNs were assessed for size, shape, margins and cystic changes. Hounsfield Units (HU) value of primary tumours and LNs were measured and tabulated. p16‐positive and p16‐negative groups were compared with respect to these variables. The two‐sample t test and two‐sample Mann–Whitney test was used.Results: A total of 364 CECT scans were reviewed with 209 patients (187 p16 positive and 22 p16 negative). Primary sites of OPSCCs were tonsils (58.8%), base of tongue (37.4%) and other oropharyngeal sites (3.8%). The HU values of p16‐positive OPSCCs with mean of 78.6HU; 95% CI (76.5–80.8) were lower for p16‐negative tumours, mean 96.0 HU CI 95% (85.5–106.6) for all oropharyngeal sub‐sites. The mean HU values of p16‐positive and p16‐negative metastatic LNs were 38.8 HU 95% CI: (13–103 HU) versus 88.7 HU 95% CI: (54–131) (P < 0.0001).Conclusions: The association between p16‐positive status and the tonsillar cancer site is very high. Imaging features of p16‐positive metastatic LNs include relatively large cystic neck nodes with low HU values. This is an imaging signature of p16‐positive OPSCCs and can potentially influence patient’s early diagnosis and prognosis.
- 1 July 2015
- Published by Elsevier in Pediatric Neurology
- Vol. 53 (1) , 47-52
High-Resolution Diffusion Tensor Imaging and Tractography in Joubert Syndrome: Beyond Molar Tooth Sign
- 1 July 2015
- Published by Elsevier in Pediatric Neurology
- Vol. 53 (1) , 47-52
High-Resolution Diffusion Tensor Imaging and Tractography in Joubert Syndrome: Beyond Molar Tooth Sign
- 8 April 2015
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 33 (5) , 279-286
High resolution CT study of the chorda tympani nerve and normal anatomical variation
The aim of this study was to define the normal anatomical variation of the course of the CTN through the mastoid temporal bone on high resolution CT (HRCT). Retrospective review of 27 consecutive normal HRCT bilateral temporal bones (n = 54, 14 males and 13 females, mean age 41 years) reconstructed at 0.4-mm slice thickness specifically measuring (1) origin of CTN from the posterior genu of the facial nerve (CNVII) and (2) the lateral-most position of the CTN from the mastoid segment of CNVII. The mean distance of the CTN origin from the mastoid segment of CNVII was 11.5 mm (standard deviation, SD = 3.2, 95 % CI 10.7–12.3) with no statistically significant difference between the left and right side observed (p = 0.08). The most lateral distance of the CTN from CNVII was a mean of 1.3 mm (SD = 0.6, 95 % CI 1.2–1.7), range 0–2.5 mm and again no statistical significance between contralateral sides was observed (p = 0.11). These measurements demonstrated an excellent level of agreement between observers as assessed by intraclass correlation calculation. Reproducible measurements demonstrate variability of the CTN in both its origin from the mastoid segment of CNVII and its lateral-most course. Precise description of the course of the CTN with HRCT may be useful for planning of otologic surgery and limiting inadvertent nerve injury.
- 8 April 2015
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 33 (5) , 279-286
High resolution CT study of the chorda tympani nerve and normal anatomical variation
The aim of this study was to define the normal anatomical variation of the course of the CTN through the mastoid temporal bone on high resolution CT (HRCT). Retrospective review of 27 consecutive normal HRCT bilateral temporal bones (n = 54, 14 males and 13 females, mean age 41 years) reconstructed at 0.4-mm slice thickness specifically measuring (1) origin of CTN from the posterior genu of the facial nerve (CNVII) and (2) the lateral-most position of the CTN from the mastoid segment of CNVII. The mean distance of the CTN origin from the mastoid segment of CNVII was 11.5 mm (standard deviation, SD = 3.2, 95 % CI 10.7–12.3) with no statistically significant difference between the left and right side observed (p = 0.08). The most lateral distance of the CTN from CNVII was a mean of 1.3 mm (SD = 0.6, 95 % CI 1.2–1.7), range 0–2.5 mm and again no statistical significance between contralateral sides was observed (p = 0.11). These measurements demonstrated an excellent level of agreement between observers as assessed by intraclass correlation calculation. Reproducible measurements demonstrate variability of the CTN in both its origin from the mastoid segment of CNVII and its lateral-most course. Precise description of the course of the CTN with HRCT may be useful for planning of otologic surgery and limiting inadvertent nerve injury.
- 1 January 2015
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 36 (1) , 16-20
18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancers
Purpose There is evidence that the status of human papilloma virus subtype 16 (HPV-p16) alters the prognosis of patients with oropharyngeal squamous cell cancer (OSCC). We sought to establish whether there is a relationship between HPV-p16 status and 18F-FDG uptake in the prognosis of OSCC. Materials and methods Patients with newly diagnosed OSCC at our institution between June 2011 and June 2012 were retrospectively evaluated. All patients underwent a baseline 18F-FDG PET/computed tomographic scan and HPV-p16 testing. Tumour maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean) and total glycolytic activity (TGA) [defined as metabolic tumour volume (MTV) multiplied by SUVmean] were measured. All PET/computed tomographic scans were reviewed on a Siemens Syngo.via (version VA11B_HF03) workstation. A designated operator defined the region of the primary tumour with the MTV segmented by 40% of the SUVmax fixed threshold method. Results Seventy-nine patients aged 27–84 years met the criteria for inclusion in the study. The types of primary tumour were tonsillar squamous cell carcinoma in 48% and base of tongue squamous cell carcinoma in 29%. The mean SUVmax was 17.5 and 17.7 in HPV-p16-positive and HPV-p16-negative groups, respectively (P=0.90). The mean MTV was 8.36 and 7.07 ml in HPV-p16-positive and HPV-p16-negative patients, respectively (P=0.42). The mean TGA values were 96.3 and 82.5 g among the HPV-p16-positive and HPV-p16-negative patients (P=0.54). There was no significant difference between HPV-p16 status and tumour grading for any of the imaging markers. Conclusion There were no statistically significant differences between HPV-p16-positive and HPV-p16-negative OSCC for any of the metabolic imaging markers (SUVmax, SUVmean, MTV and TGA) measured in this study.
- 1 January 2015
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 36 (1) , 16-20
18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancers
Purpose There is evidence that the status of human papilloma virus subtype 16 (HPV-p16) alters the prognosis of patients with oropharyngeal squamous cell cancer (OSCC). We sought to establish whether there is a relationship between HPV-p16 status and 18F-FDG uptake in the prognosis of OSCC. Materials and methods Patients with newly diagnosed OSCC at our institution between June 2011 and June 2012 were retrospectively evaluated. All patients underwent a baseline 18F-FDG PET/computed tomographic scan and HPV-p16 testing. Tumour maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean) and total glycolytic activity (TGA) [defined as metabolic tumour volume (MTV) multiplied by SUVmean] were measured. All PET/computed tomographic scans were reviewed on a Siemens Syngo.via (version VA11B_HF03) workstation. A designated operator defined the region of the primary tumour with the MTV segmented by 40% of the SUVmax fixed threshold method. Results Seventy-nine patients aged 27–84 years met the criteria for inclusion in the study. The types of primary tumour were tonsillar squamous cell carcinoma in 48% and base of tongue squamous cell carcinoma in 29%. The mean SUVmax was 17.5 and 17.7 in HPV-p16-positive and HPV-p16-negative groups, respectively (P=0.90). The mean MTV was 8.36 and 7.07 ml in HPV-p16-positive and HPV-p16-negative patients, respectively (P=0.42). The mean TGA values were 96.3 and 82.5 g among the HPV-p16-positive and HPV-p16-negative patients (P=0.54). There was no significant difference between HPV-p16 status and tumour grading for any of the imaging markers. Conclusion There were no statistically significant differences between HPV-p16-positive and HPV-p16-negative OSCC for any of the metabolic imaging markers (SUVmax, SUVmean, MTV and TGA) measured in this study.
- 1 November 2014
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 21 (11) , 2046
41.
- Open Access
- 1 November 2012
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 6, 1921-4
Scedosporium apiospermum endophthalmitis: diffusion-weighted imaging in detecting subchoroidal abscess
Peer reviewed article authored by (Bhuta S, Hsu CC, Kwan GN). Read article or submit your manuscript for publishing.
- 1 November 2012
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 6, 1921-4
Open AccessScedosporium apiospermum endophthalmitis: diffusion-weighted imaging in detecting subchoroidal abscess
Peer reviewed article authored by (Bhuta S, Hsu CC, Kwan GN). Read article or submit your manuscript for publishing.
- 18 April 2012
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 26 (5) , 668-673
Rosette-forming glioneuronal tumour: Imaging features, histopathological correlation and a comprehensive review of literature
Background. Rosette-forming glioneuronal tumour (RGNT) is a rare and novel brain tumour. We present a case of rosette forming glioneuronal tumour of the fourth ventricle and highlight the imaging and histological features of this tumour entity. We also performed a comprehensive review of the imaging features, treatments and outcomes of all past cases and make recommendations on diagnosis and management. Method. We conducted a PUBMED search using the words ‘rosette forming glioneuronal tumour’, and identified 48 cases of rosette forming glioneuronal tumour. We reviewed the location, imaging features of this rare tumour entity as well as the treatment and follow-up. We also present a case of a 42-year-old man with an incidental finding of a solid-cystic midline mass in the posterior fossa at the level of fourth ventricle with morphological features and immunohistochemical characteristic of a RGNT (WHO Grade I). Findings. RGNT is commonly found in association with the fourth ventricle often with local extension; however, it is known to occur at sites outside of its usual location. RGNT can demonstrate solid, cystic or mixed features on MRI and frequently shows focal contrast enhancement. It is often associated with an element of hydrocephalus. Gross or subtotal tumour resection was the most common treatment of choice. Due to the intimate relationship of these tumours to key neural structures in the cerebellum, variable degrees of postoperative neurological deficits were reported in half of the patients. Among the reported cases, no evidence of recurrence following gross or subtotal resection of tumour was seen in the majority of patients. However, owing to lack of lengthy follow-up, we recommend routine imaging follow-up. Conclusion. Knowledge of this tumour is of importance as they are relatively slow growing and exhibit benign histological characteristics, thus depending on its location maybe amenable to gross total resection.
- 18 April 2012
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 26 (5) , 668-673
Rosette-forming glioneuronal tumour: Imaging features, histopathological correlation and a comprehensive review of literature
Background. Rosette-forming glioneuronal tumour (RGNT) is a rare and novel brain tumour. We present a case of rosette forming glioneuronal tumour of the fourth ventricle and highlight the imaging and histological features of this tumour entity. We also performed a comprehensive review of the imaging features, treatments and outcomes of all past cases and make recommendations on diagnosis and management. Method. We conducted a PUBMED search using the words ‘rosette forming glioneuronal tumour’, and identified 48 cases of rosette forming glioneuronal tumour. We reviewed the location, imaging features of this rare tumour entity as well as the treatment and follow-up. We also present a case of a 42-year-old man with an incidental finding of a solid-cystic midline mass in the posterior fossa at the level of fourth ventricle with morphological features and immunohistochemical characteristic of a RGNT (WHO Grade I). Findings. RGNT is commonly found in association with the fourth ventricle often with local extension; however, it is known to occur at sites outside of its usual location. RGNT can demonstrate solid, cystic or mixed features on MRI and frequently shows focal contrast enhancement. It is often associated with an element of hydrocephalus. Gross or subtotal tumour resection was the most common treatment of choice. Due to the intimate relationship of these tumours to key neural structures in the cerebellum, variable degrees of postoperative neurological deficits were reported in half of the patients. Among the reported cases, no evidence of recurrence following gross or subtotal resection of tumour was seen in the majority of patients. However, owing to lack of lengthy follow-up, we recommend routine imaging follow-up. Conclusion. Knowledge of this tumour is of importance as they are relatively slow growing and exhibit benign histological characteristics, thus depending on its location maybe amenable to gross total resection.